Deciphera gets Canadian approval for QINLOCK for fourth-line gastrointestinal stromal tumour

This article was originally published here

The QINLOCK New Drug Submission was approved by Health Canada under Project Orbis, an initiative of the U.S. Food and Drug Administration’s (FDA) Oncology Center of Excellence designed

The post Deciphera gets Canadian approval for QINLOCK for fourth-line gastrointestinal stromal tumour appeared first on Pharmaceutical Business review.

0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply